The Market Reports

Index

1 Anti-TNF-α Monoclonal Antibody Market Overview
1.1 Product Overview and Scope of Anti-TNF-α Monoclonal Antibody
1.2 Anti-TNF-α Monoclonal Antibody Segment by Type
1.2.1 Global Anti-TNF-α Monoclonal Antibody Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Adalimumab
1.2.3 Golimumab
1.2.4 Infliximab
1.2.5 Pecerizumab
1.3 Anti-TNF-α Monoclonal Antibody Segment by Application
1.3.1 Anti-TNF-α Monoclonal Antibody Sales Comparison by Application: (2021-2027)
1.3.2 Rheumatoid Arthritis
1.3.3 Ankylosing Spondylitis
1.3.4 Psoriasis
1.3.5 Other
1.4 Global Anti-TNF-α Monoclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-TNF-α Monoclonal Antibody Revenue 2016-2027
1.4.2 Global Anti-TNF-α Monoclonal Antibody Sales 2016-2027
1.4.3 Anti-TNF-α Monoclonal Antibody Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anti-TNF-α Monoclonal Antibody Market Competition by Manufacturers
2.1 Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-TNF-α Monoclonal Antibody Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-TNF-α Monoclonal Antibody Manufacturing Sites, Area Served, Product Type
2.5 Anti-TNF-α Monoclonal Antibody Market Competitive Situation and Trends
2.5.1 Anti-TNF-α Monoclonal Antibody Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-TNF-α Monoclonal Antibody Players Market Share by Revenue
2.5.3 Global Anti-TNF-α Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anti-TNF-α Monoclonal Antibody Retrospective Market Scenario by Region
3.1 Global Anti-TNF-α Monoclonal Antibody Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-TNF-α Monoclonal Antibody Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-TNF-α Monoclonal Antibody Market Facts & Figures by Country
3.3.1 North America Anti-TNF-α Monoclonal Antibody Sales by Country
3.3.2 North America Anti-TNF-α Monoclonal Antibody Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-TNF-α Monoclonal Antibody Market Facts & Figures by Country
3.4.1 Europe Anti-TNF-α Monoclonal Antibody Sales by Country
3.4.2 Europe Anti-TNF-α Monoclonal Antibody Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-TNF-α Monoclonal Antibody Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-TNF-α Monoclonal Antibody Sales by Region
3.5.2 Asia Pacific Anti-TNF-α Monoclonal Antibody Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-TNF-α Monoclonal Antibody Market Facts & Figures by Country
3.6.1 Latin America Anti-TNF-α Monoclonal Antibody Sales by Country
3.6.2 Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country
3.7.2 Middle East and Africa Anti-TNF-α Monoclonal Antibody Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-TNF-α Monoclonal Antibody Historic Market Analysis by Type
4.1 Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2016-2021)
4.2 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2016-2021)
4.3 Global Anti-TNF-α Monoclonal Antibody Price by Type (2016-2021)

5 Global Anti-TNF-α Monoclonal Antibody Historic Market Analysis by Application
5.1 Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2016-2021)
5.2 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2016-2021)
5.3 Global Anti-TNF-α Monoclonal Antibody Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Abbive
6.1.1 Abbive Corporation Information
6.1.2 Abbive Description and Business Overview
6.1.3 Abbive Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbive Product Portfolio
6.1.5 Abbive Recent Developments/Updates
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Description and Business Overview
6.2.3 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Johnson and Johnson Product Portfolio
6.2.5 Johnson and Johnson Recent Developments/Updates
6.3 UCB
6.3.1 UCB Corporation Information
6.3.2 UCB Description and Business Overview
6.3.3 UCB Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2016-2021)
6.3.4 UCB Product Portfolio
6.3.5 UCB Recent Developments/Updates

7 Anti-TNF-α Monoclonal Antibody Manufacturing Cost Analysis
7.1 Anti-TNF-α Monoclonal Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-TNF-α Monoclonal Antibody
7.4 Anti-TNF-α Monoclonal Antibody Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-TNF-α Monoclonal Antibody Distributors List
8.3 Anti-TNF-α Monoclonal Antibody Customers

9 Anti-TNF-α Monoclonal Antibody Market Dynamics
9.1 Anti-TNF-α Monoclonal Antibody Industry Trends
9.2 Anti-TNF-α Monoclonal Antibody Growth Drivers
9.3 Anti-TNF-α Monoclonal Antibody Market Challenges
9.4 Anti-TNF-α Monoclonal Antibody Market Restraints

10 Global Market Forecast
10.1 Anti-TNF-α Monoclonal Antibody Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-TNF-α Monoclonal Antibody by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-TNF-α Monoclonal Antibody by Type (2022-2027)
10.2 Anti-TNF-α Monoclonal Antibody Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-TNF-α Monoclonal Antibody by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-TNF-α Monoclonal Antibody by Application (2022-2027)
10.3 Anti-TNF-α Monoclonal Antibody Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-TNF-α Monoclonal Antibody by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-TNF-α Monoclonal Antibody by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Anti-TNF-α Monoclonal Antibody Sales (KG) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-TNF-α Monoclonal Antibody Sales (KG) Comparison by Application (2021-2027)
Table 3. Global Anti-TNF-α Monoclonal Antibody Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-TNF-α Monoclonal Antibody Covered in This Study
Table 5. Global Anti-TNF-α Monoclonal Antibody Sales (KG) of Key Manufacturers (2016-2021)
Table 6. Global Anti-TNF-α Monoclonal Antibody Sales Share by Manufacturers (2016-2021)
Table 7. Global Anti-TNF-α Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-TNF-α Monoclonal Antibody Average Price (USD/KG) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-TNF-α Monoclonal Antibody Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-TNF-α Monoclonal Antibody Product Type
Table 12. Global Anti-TNF-α Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-TNF-α Monoclonal Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-TNF-α Monoclonal Antibody as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2016-2021) & (KG)
Table 16. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2016-2021)
Table 17. Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-TNF-α Monoclonal Antibody Sales by Country (2016-2021) & (KG)
Table 19. North America Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2016-2021)
Table 20. North America Anti-TNF-α Monoclonal Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2016-2021) & (KG)
Table 23. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-TNF-α Monoclonal Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-TNF-α Monoclonal Antibody Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-TNF-α Monoclonal Antibody Sales by Region (2016-2021) & (KG)
Table 27. Asia Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-TNF-α Monoclonal Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-TNF-α Monoclonal Antibody Sales by Country (2016-2021) & (KG)
Table 31. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country (2016-2021) & (KG)
Table 35. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-TNF-α Monoclonal Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-TNF-α Monoclonal Antibody Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-TNF-α Monoclonal Antibody Sales (KG) by Type (2016-2021)
Table 39. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2016-2021)
Table 40. Global Anti-TNF-α Monoclonal Antibody Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Type (2016-2021)
Table 42. Global Anti-TNF-α Monoclonal Antibody Price (USD/KG) by Type (2016-2021)
Table 43. Global Anti-TNF-α Monoclonal Antibody Sales (KG) by Application (2016-2021)
Table 44. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2016-2021)
Table 45. Global Anti-TNF-α Monoclonal Antibody Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Application (2016-2021)
Table 47. Global Anti-TNF-α Monoclonal Antibody Price (USD/KG) by Application (2016-2021)
Table 48. Abbive Corporation Information
Table 49. Abbive Description and Business Overview
Table 50. Abbive Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 51. Abbive Anti-TNF-α Monoclonal Antibody Product
Table 52. Abbive Recent Developments/Updates
Table 53. Johnson and Johnson Corporation Information
Table 54. Johnson and Johnson Description and Business Overview
Table 55. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 56. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Product
Table 57. Johnson and Johnson Recent Developments/Updates
Table 58. UCB Corporation Information
Table 59. UCB Description and Business Overview
Table 60. UCB Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2016-2021)
Table 61. UCB Anti-TNF-α Monoclonal Antibody Product
Table 62. UCB Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Anti-TNF-α Monoclonal Antibody Distributors List
Table 66. Anti-TNF-α Monoclonal Antibody Customers List
Table 67. Anti-TNF-α Monoclonal Antibody Market Trends
Table 68. Anti-TNF-α Monoclonal Antibody Growth Drivers
Table 69. Anti-TNF-α Monoclonal Antibody Market Restraints
Table 70. Global Anti-TNF-α Monoclonal Antibody Sales Forecast by Type (2022-2027) & (KG)
Table 71. Global Anti-TNF-α Monoclonal Antibody Sales Market Share Forecast by Type (2022-2027)
Table 72. Global Anti-TNF-α Monoclonal Antibody Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 73. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share Forecast by Type (2022-2027)
Table 74. Global Anti-TNF-α Monoclonal Antibody Sales Forecast by Application (2022-2027) & (KG)
Table 75. Global Anti-TNF-α Monoclonal Antibody Sales Market Share Forecast by Application (2022-2027)
Table 76. Global Anti-TNF-α Monoclonal Antibody Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 77. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share Forecast by Application (2022-2027)
Table 78. Global Anti-TNF-α Monoclonal Antibody Sales Forecast by Region (2022-2027) & (KG)
Table 79. Global Anti-TNF-α Monoclonal Antibody Sales Market Share Forecast by Region (2022-2027)
Table 80. Global Anti-TNF-α Monoclonal Antibody Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 81. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share Forecast by Region (2022-2027)
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-TNF-α Monoclonal Antibody
Figure 2. Global Anti-TNF-α Monoclonal Antibody Market Share by Type in 2020 & 2027
Figure 3. Adalimumab Product Picture
Figure 4. Golimumab Product Picture
Figure 5. Infliximab Product Picture
Figure 6. Pecerizumab Product Picture
Figure 7. Global Anti-TNF-α Monoclonal Antibody Market Share by Application in 2020 & 2027
Figure 8. Rheumatoid Arthritis
Figure 9. Ankylosing Spondylitis
Figure 10. Psoriasis
Figure 11. Other
Figure 12. Global Anti-TNF-α Monoclonal Antibody Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anti-TNF-α Monoclonal Antibody Market Size 2016-2027 (US$ Million)
Figure 14. Global Anti-TNF-α Monoclonal Antibody Sales 2016-2027 (KG)
Figure 15. Global Anti-TNF-α Monoclonal Antibody Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Anti-TNF-α Monoclonal Antibody Sales Share by Manufacturers in 2020
Figure 17. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Anti-TNF-α Monoclonal Antibody Players: Market Share by Revenue in 2020
Figure 19. Anti-TNF-α Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2016-2021)
Figure 21. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region in 2020
Figure 22. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region (2016-2021)
Figure 23. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region in 2020
Figure 24. U.S. Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Anti-TNF-α Monoclonal Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Anti-TNF-α Monoclonal Antibody by Type (2016-2021)
Figure 49. Sales Market Share of Anti-TNF-α Monoclonal Antibody by Application (2016-2021)
Figure 50. Sales Market Share of Anti-TNF-α Monoclonal Antibody by Application in 2020
Figure 51. Revenue Share of Anti-TNF-α Monoclonal Antibody by Application (2016-2021)
Figure 52. Revenue Share of Anti-TNF-α Monoclonal Antibody by Application in 2020
Figure 53. Manufacturing Cost Structure of Anti-TNF-α Monoclonal Antibody
Figure 54. Manufacturing Process Analysis of Anti-TNF-α Monoclonal Antibody
Figure 55. Anti-TNF-α Monoclonal Antibody Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed